94 related articles for article (PubMed ID: 3213038)
1. [Hemostatic studies in decompensated diabetes mellitus].
Petrunova N; Genova V
Vutr Boles; 1988; 27(5):43-6. PubMed ID: 3213038
[TBL] [Abstract][Full Text] [Related]
2. [Fibrinogen-fibrin degradation products in diabetes mellitus].
Alakhverdian R; Koev D
Vutr Boles; 1987; 26(6):72-5. PubMed ID: 3125689
[TBL] [Abstract][Full Text] [Related]
3. [Endothelium and diabetes: study of plasma levels of endothelin-1 in diabetic patients with arterial hypertension or proliferative retinopathy].
Parlapiano C; Paoletti V; Campana E; Rota C; Donnarumma L; Musca A; Andreani D
Minerva Med; 1995 Mar; 86(3):105-20. PubMed ID: 7603606
[No Abstract] [Full Text] [Related]
4. [The role of the system of hemostasis in the development of vascular lesions in diabetes mellitus].
Lapotnikov VA; Moiseev SI
Ter Arkh; 1988; 60(9):31-5. PubMed ID: 3217876
[TBL] [Abstract][Full Text] [Related]
5. [Multivariate analysis for the understanding of typical diabetic hemostasis criteria. 1: Plasma markers].
Syrbe G; Schröder H; Keil E; Jütte A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(5):717-23. PubMed ID: 1709905
[TBL] [Abstract][Full Text] [Related]
6. [Changes in thrombocytic hemostasis in patients with diabetic glomerulosclerosis].
Belitskaia GA; Lapchinskaia II; Donish RM; Ishchenko VM; Fedorova NE; Glebova AN; Kozlenko VM; Korobko VF; Sobolevskaia NV
Vrach Delo; 1991 Jul; (7):66-9. PubMed ID: 1771840
[TBL] [Abstract][Full Text] [Related]
7. [Antithrombin III and alpha-2-antiplasmin activities compared with other hemostasis parameters in uncomplicated diabetes mellitus, type 2].
Kotschy M; Drewniak W; Graczykowska-Koczorowska A; Listopadzki D
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):17-8. PubMed ID: 1409034
[TBL] [Abstract][Full Text] [Related]
8. [Proteinases inhibitors in sera of diabetic patients with non-proliferative retinopathy].
Skopiński P; Duda-Król B; Lipińska A; Sommer E; Borowska A; Filewska M; Szaflik J; Skopińska-Rózewska E; Struzik E
Klin Oczna; 2004; 106(3 Suppl):424-6. PubMed ID: 15636223
[TBL] [Abstract][Full Text] [Related]
9. Rheological changes in diabetic microangiopathy.
Negrean V; Suciu I; Sâmpelean D; Cozma A
Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
[TBL] [Abstract][Full Text] [Related]
10. [Basal blood level of thyroxine in diabetes mellitus patients].
Vakov L; Zakharieva B
Vutr Boles; 1987; 26(1):60-5. PubMed ID: 3590731
[TBL] [Abstract][Full Text] [Related]
11. [Hemorheologic and coagulation study in a group of patients with diabetic retinopathy].
Parenti M; Pasquali R; Sorrenti G; Babini AC; Melchionda N; Palareti G; Poggi M; Tricarico G
G Clin Med; 1984; 65(9-10):409-18. PubMed ID: 6442246
[No Abstract] [Full Text] [Related]
12. [Ophthalmologic consequences of diabetes mellitus: social-hygienic and clinical aspects].
Chumaeva EA
Vestn Oftalmol; 2003; 119(5):43-5. PubMed ID: 14598496
[No Abstract] [Full Text] [Related]
13. [Blood viscosity and erythrocyte deformability in diabetic retinopathy].
Melli M; Poggi M; Codeluppi L; Baraldi P; Torlai F; Peduzzi M
Ric Clin Lab; 1983; 13 Suppl 3():371-4. PubMed ID: 6673016
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolysis in diabetes mellitus. Role of overweight and hypertriglyceridemia.
Cucuianu M; Fekete T; Marcusiu C; Mösler R; Duţu A
Med Interne; 1984; 22(3):171-7. PubMed ID: 6494764
[TBL] [Abstract][Full Text] [Related]
15. [Determination of N-acetyl-glucosaminidase (NAG) in diabetic subjects].
Melosi A; Ricci F
Quad Sclavo Diagn; 1983 Mar; 19(1):113-20. PubMed ID: 6675040
[TBL] [Abstract][Full Text] [Related]
16. [Basal blood level of serotonin in diabetes mellitus patients].
Vakov L
Vutr Boles; 1984; 23(1):79-84. PubMed ID: 6730455
[TBL] [Abstract][Full Text] [Related]
17. [The efficacy of the antiaggregants ticlid and diabeton in correcting chronic intravascular microcoagulation of the blood in diabetic patients].
Velikov VK; Saltykov BB; Galkina AK; Kabaeva EV; Frolova AI; Privalova EV; Savina TS; Zelenchuk NM; Shubina OI; Iarovaia LD
Ter Arkh; 1991; 63(10):44-9. PubMed ID: 1805420
[TBL] [Abstract][Full Text] [Related]
18. Plasma prekallikrein as a risk factor for diabetic retinopathy.
Kedzierska K; Ciechanowski K; Gołembiewska E; Safranow K; Ciechanowicz A; Domański L; Myślak M; Róźański J
Arch Med Res; 2005; 36(5):539-43. PubMed ID: 16099335
[TBL] [Abstract][Full Text] [Related]
19. [Behavior of fibrinogen in diabetic patients in comparison with objective vascular measurements in the ocular fundus].
Syrbe G; Oswald B; Jorke D; Jütte A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):853-8. PubMed ID: 2419213
[TBL] [Abstract][Full Text] [Related]
20. Coagulation factors of contact phase of haemostasis are normal in well-controlled type-I diabetic patients despite presence of diabetic retinopathy.
Watzke H; Schernthaner G; Schnack C; Schwarz HP; Prskavec F; Freyler H
Diabetes Res; 1988 Apr; 7(4):197-200. PubMed ID: 3402169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
